Jeffrey Miller is president and CEO of NewArc Investments, a registered investment adviser, and Capital Markets Research. He also serves on the board of directors for Helix BioMedix and Think-A-Move. Miller has been director of research for KTZ Trading, and taught political science and public affairs for the University of Wisconsin and Lawrence University. Miller is the author of numerous articles and papers on taxation, policymaking and the equities market. He holds a bachelor’s degree from Bowling Green State University and master’s and doctorate degrees from the University of Michigan.
Miller writes about the market, interpreting data, and finding the right expert at his blog, “A Dash of Insight. He is writing about the 2008 presidential campaign and the implications for individual stocks and the market at Election Stocks. His investment company, with programs for both individual and institutional investors, is NewArc Investments.
To chat with Jeff Miller about his Investment strategies, please sign up for a WallStreetAllStars.com platinum subscription and click here.
Jeff’s latest columns:
IAI is the iShares U.S. Broker Dealers ETF and it is ranked number 5 on Felix’s hit parade. Felix has been consistent over the last month, so we have already covered several of the top-rated ETF. FXI was last week’s feature. We have discussed the second highest rated ETF, IBB three weeks ago. And, we […]
FXI is iShares FTSE China Large-Cap ETF. It is number one on our list. It is still in the penalty box, as it was last week (to see last week’s results click here.) But, FXI has jumped from rating of 47 to 75 this week. We have our eyes peeled (like last night’s potatoes) for this […]
Over the last few weeks I have highlighted several changing market concerns. We worried about the government shutdown and the debt ceiling. More recently my emphasis has moved from earnings and seasonal worries, to the possibility of a year-end rally. Last week we highlighted the “bubble talk” and that proved to be a [...]
IHE is the iShares U.S. Pharmaceuticals ETF. Although, this is not a buy right now because it is in the penalty box, it is a good follow up story to last week’s article on biotech (IBB). The current ratings illustrate what a hot topic healthcare is right now. ETFs like this frequently emerge from the […]
Continuing with the Eight Traits of the Insightful Investor…. The Insightful Investor is open to other viewpoints. Every question can be approached this way. It is a useful investment skill, but it requires discipline. It is so easy to fall in love with your own ideas and positions. It is especially dangerous when you [...]
Wall Street All-Stars RSS» Jeff Miller